BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng L, Qiu X, He L, Liu L. MicroRNA-122-5p ameliorates tubular injury in diabetic nephropathy via FIH-1/HIF-1α pathway. Ren Fail 2022;44:293-303. [PMID: 35166173 DOI: 10.1080/0886022X.2022.2039194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ismail A, El-Mahdy HA, Eldeib MG, Doghish AS. miRNAs as cornerstones in diabetic microvascular complications. Mol Genet Metab 2023;138:106978. [PMID: 36565688 DOI: 10.1016/j.ymgme.2022.106978] [Reference Citation Analysis]
2 Li H, Dai W, Liu Z, He L. Renal Proximal Tubular Cells: A New Site for Targeted Delivery Therapy of Diabetic Kidney Disease. Pharmaceuticals (Basel) 2022;15. [PMID: 36558944 DOI: 10.3390/ph15121494] [Reference Citation Analysis]
3 Liu H, Li Y, Xiong J. The Role of Hypoxia-Inducible Factor-1 Alpha in Renal Disease. Molecules 2022;27:7318. [DOI: 10.3390/molecules27217318] [Reference Citation Analysis]
4 Chen Y, Zhou X, Wu Y. The miR-26a-5p/IL-6 axis alleviates sepsis-induced acute kidney injury by inhibiting renal inflammation. Renal Failure 2022;44:551-61. [DOI: 10.1080/0886022x.2022.2056486] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 潘 路. Research Progress of MicroRNA-122 in Obesity and Type 2 Diabetes. ACM 2022;12:5706-5712. [DOI: 10.12677/acm.2022.126824] [Reference Citation Analysis]